Los Angeles, CA127 Active Studies

Atopic Dermatitis Clinical Trials in Los Angeles, CA

Find 127 actively recruiting atopic dermatitis clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

127
Active Trials
98
Sponsors
54,037
Enrolling

Recruiting Atopic Dermatitis Studies in Los Angeles

About Atopic Dermatitis Clinical Trials in Los Angeles

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 127 atopic dermatitis clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 54,037 participants. Research is being sponsored by Photocure, American Society of Clinical Oncology, Merck Sharp & Dohme LLC and 95 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Los Angeles — FAQ

Are there atopic dermatitis clinical trials in Los Angeles?

Yes, there are 127 atopic dermatitis clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 127 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated October 12, 2026 from ClinicalTrials.gov